Inhibikase Therapeutics

Price & Volume

Stats

52W Range	$1.12-$4.20
Market Cap	$218.3M
Shares Short	672,186

Financials

Revenue (12 Mos)	$79,570
Revenue Growth (YoY)	-100%
Gross Profit (12 Mos)	-$8.2M
Diluted EPS	-$3.12

News

Yahoo Finance • last year

Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period Activity

Yahoo Finance • last year

Correcting & Replacing -- Inhibikase Therapeutics to Report Third Quarter Financial Results on November 14, 2023

Yahoo Finance • last year

Inhibikase Therapeutics to Report Second Quarter Financial Results on November 14, 2023

Yahoo Finance • last year

Inhibikase Therapeutics Highlights Unblinded Functional Analysis from the 201 Trial of Risvodetinib in Untreated Parkinson’s Disease and Provides Update on Ongoing Enrollment

About

CEO	Dr. Milton H. Werner Ph.D.
Address	3350 Riverwood Parkway SE, Atlanta, GA, United States, 30339
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	8